大麻素改善L-DOPA诱导的运动障碍,调节神经炎症和内分泌,内分泌和尼特基系统
Glauce Crivelaro Nascimento1, Gabriela Gonçalves Bálico1, Bianca Andretto de Mattos2
1University of São Paulo (USP), School of Dentistry of Ribeirão Preto, Department of Basic and Oral Biology, Av. Café S/N, 14040-904 Ribeirão Preto, SP, Brazil.
概括
大麻素 (CBD) 和其衍生品PECS-101在帕金森病模型中有效降低L-DOPA诱导的运动障碍. 这些化合物可以缓解异常运动而不损害运动功能,提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 大麻素研究 研究 大麻素研究
背景情况:
- L-3,4-二基氨酸 (L-DOPA) 是帕金森病 (PD) 的首要治疗方法,但L-DOPA诱导的动力障碍 (LID) 构成了重大挑战.
- 内分泌大麻素系统是管理LID的潜在目标.
研究的目的:
- 调查大麻 (CBD) 和其衍生品PECS-101在缓解LID方面的疗效.
- 探索CBD抗动作用背后的机制.
主要方法:
- 单边6二多巴胺损伤的老鼠被给予L-DOPA以诱导运动障碍.
- 在L-DOPA治疗的最后两周内,CBD和PECS-101被给予.
- 分析了生物化学标记物 (Fos-B,p-ERK,内分泌素,炎症标记物) 和受体相互作用 (CB1,PPARγ,TRPV-1).
主要成果:
- CBD和PECS-101显著降低了非正常的非自愿运动 (AIM),而不会影响L-DOPA的运动效果.
- CBD的效果涉及状Fos-B和-ERK的减少,并由CB1和PPARγ受体调解.
- CBD增加了安纳米德和2-阿拉基多诺伊尔糖醇水平,并降低了神经炎症标志物.
结论:
- 在PD大鼠模型中,CBD和PECS-101显示出显著的抗肌动力潜力.
- 通过与性神经递质,TRPV-1,CB1和PPARγ受体的相互作用,CBD可以缓解LID.
- 这些发现强调了CBD作为一种潜在的治疗剂,用于治疗帕金森病中的LID.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
369
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
369
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
334
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
334
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
626
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
626
01:24Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
331
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
331